Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepicastat for PTSD in OIF/OEF Veterans
NCT00659230Phase 2Completed
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nepicastat in post-traumatic stress disorder (PTSD), sponsored by Tuscaloosa Research and Education Advancement Corporation. Started Jul 2009; status: completed.
02
Drugs
nepicastat
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00659230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659230.